Neurochemical analysis of amino acids, polyamines and carboxylic acids: GC-MS quantitation of tBDMS derivatives using ammonia positive chemical ionization.
The GC-MS quantitation of a large number of neurochemicals utilizing a single derivatization step is not common but is provided by the reagent N-(tert-butyldimethylsilyl)-N-methyltrifluro-acetamide (MTBSTFA). Previous workers have utilized this derivative for GC-MS analyses of amino acids, carboxylic acids and urea with electron impact (EI) and with positive chemical ionization (PCI; methane as reagent gas). However, these conditions yield significant fragmentation, decreasing sensitivity and in some cases reducing specificity for quantitation with selected ion monitoring (SIM). Additionally, the majority of studies have used a single internal standard to quantitate many compounds. In this study we demonstrate that using isotopic dilution combined with ammonia as the reagent gas for PCI analyses, results in high precision and sensitivity in analyzing complex neurochemical mixes. We also demonstrate for the first time the utility of this derivative for the analysis of brain polyamines and the dipeptide cysteinyl glycine. In the case of ammonia as the reagent gas, all amino acids, polyamines and urea yielded strong [MH](+) ions with little or no fragmentation. In the case of carboxylic acids, [M+18](+) ions predominated but [MH](+) ions were also noted. This approach was used to analyze superfusates from hippocampal brain slices and brain tissue extracts from brain lesion studies. The advantages of this methodology include: (i) simple sample preparation; (ii) a single derivatization step; (iii) direct GC-MS analysis of the reaction mix; (iv) high precision as a result of isotopic dilution analyses; (v) high sensitivity and specificity as a result of strong [MH](+) ions with ammonia reagent gas; (vi) no hydrolysis of glutamine to glutamate or asparagine to aspartate; and (vii) applicability to a wide range of neurochemicals.
Wood
Paul L
PL
The Falk Center for Molecular Therapeutics, Department of Biomedical Engineering, McCormick School of Engineering and Applied Sciences, Northwestern University, 1801 Maple Avenue, Suite 4306, Evanston, IL 60201, USA. p-wood@northwestern.edu
Khan
M Amin
MA
Moskal
Joseph R
JR
D000081:Acetamides; D000596:Amino Acids / Q000032:analysis*; D000641:Ammonia; D000818:Animals; D002247:Carbon Isotopes; D002264:Carboxylic Acids / Q000032:analysis*; D003903:Deuterium; D005463:Fluoroacetates; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods*; D006624:Hippocampus / Q000737:chemistry* / Q000187:drug effects; D008297:Male; D018377:Neurotransmitter Agents / Q000378:metabolism; D009587:Nitrogen Isotopes; D017646:Organosilicon Compounds / Q000032:analysis* / Q000737:chemistry; D011073:Polyamines / Q000032:analysis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014269:Trifluoroacetic Acid / Q000737:chemistry; D014298:Trimethyltin Compounds / Q000633:toxicity
D000081:Acetamides; D000596:Amino Acids; D002247:Carbon Isotopes; D002264:Carboxylic Acids; D005463:Fluoroacetates; D018377:Neurotransmitter Agents; D009587:Nitrogen Isotopes; D017646:Organosilicon Compounds; D011073:Polyamines; D014298:Trimethyltin Compounds; C009660:t-butyldimethylsilyl compounds; C046488:trimethyltin; D000641:Ammonia; C059151:N-methyl-N-(tert-butyldimethylsilyl)trifluoroacetamide; D003903:Deuterium; D014269:Trifluoroacetic Acid